Literature DB >> 26143342

Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis.

Won Sohn1, Dae Won Jun2, Kang Nyeong Lee3, Hang Lak Lee3, Oh Young Lee3, Ho Soon Choi3, Byung Chul Yoon3.   

Abstract

BACKGROUND AND AIMS: Gut microbiota may be associated with the pathogenesis of nonalcoholic steatohepatitis (NASH). This study aimed to investigate the protective effects and possible mechanisms of Lactobacillus paracasei on NASH.
METHODS: Thirty male C57BL/6 mice were randomized into three groups and maintained for 10 weeks: control group (standard chow), NASH model group (high fat + 10 % fructose diet), and the L. paracasei group (NASH model with L. paracasei). Liver histology, serum aminotransferase levels, and hepatic gene expression levels were measured. Intestinal permeability was investigated using urinary (51)Creatinine Ethylenediaminetetraacetic acid ((51)Cr-EDTA) clearance. Total Kupffer cell counts and their composition (M1 vs. M2 Kupffer cells) were measured using flow cytometry with F4/80 and CD206 antibodies.
RESULTS: Hepatic fat deposition, serum ALT level, and (51)Cr-EDTA clearance were significantly lower in the L. paracasei group than the NASH group (p < 0.05). The L. paracasei group had lower expression in Toll-like receptor-4 (TLR-4), NADPH oxidase-4 (NOX-4), tumor necrosis factor alpha (TNF-α), monocyte chemotactic protein-1 (MCP-1), interleukin 4 (IL-4), peroxisome proliferator activated receptor gamma (PPAR-γ), and PPAR-δ compared with the NASH group (p < 0.05). The total number of F4/80(+) Kupffer cells was lower in the L. paracasei group than the NASH group. L. paracasei induced the fraction of F4/80(+)CD206(+) cells (M2 Kupffer cells) while F4/80(+)CD206(-) cells (M1 Kupffer cells) were higher in the NASH group (F4/80(+)CD206(+) cell: 44% in NASH model group vs. 62% in L. paracasei group, p < 0.05).
CONCLUSIONS: Lactobacillus paracasei attenuates hepatic steatosis with M2-dominant Kupffer cell polarization in a NASH model.

Entities:  

Keywords:  Kupffer cells; Lactobacillus; Nonalcoholic steatohepatitis; Probiotics

Mesh:

Substances:

Year:  2015        PMID: 26143342     DOI: 10.1007/s10620-015-3770-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

Review 1.  The lactic acid bacteria: a literature survey.

Authors:  Frank J Carr; Don Chill; Nino Maida
Journal:  Crit Rev Microbiol       Date:  2002       Impact factor: 7.624

Review 2.  Macrophage polarization in metabolic disorders: functions and regulation.

Authors:  Giulia Chinetti-Gbaguidi; Bart Staels
Journal:  Curr Opin Lipidol       Date:  2011-10       Impact factor: 4.776

3.  M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.

Authors:  Jinghong Wan; Merieme Benkdane; Fatima Teixeira-Clerc; Stéphanie Bonnafous; Alexandre Louvet; Fouad Lafdil; Françoise Pecker; Albert Tran; Philippe Gual; Ariane Mallat; Sophie Lotersztajn; Catherine Pavoine
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

4.  Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice.

Authors:  D M McCafferty; M Miampamba; E Sihota; K A Sharkey; P Kubes
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 5.  Role of Kupffer cells in host defense and liver disease.

Authors:  Manfred Bilzer; Frigga Roggel; Alexander L Gerbes
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

Review 6.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

7.  Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4).

Authors:  Linda Aronsson; Ying Huang; Paolo Parini; Marion Korach-André; Janet Håkansson; Jan-Åke Gustafsson; Sven Pettersson; Velmurugesan Arulampalam; Joseph Rafter
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

8.  Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice.

Authors:  Yan Y Lam; Connie W Y Ha; Craig R Campbell; Andrew J Mitchell; Anuwat Dinudom; Jan Oscarsson; David I Cook; Nicholas H Hunt; Ian D Caterson; Andrew J Holmes; Len H Storlien
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

9.  Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis.

Authors:  Manuel Oliveira; Nabil Bosco; Genevieve Perruisseau; Jeanne Nicolas; Iris Segura-Roggero; Stéphane Duboux; Muriel Briand; Stéphanie Blum; Jalil Benyacoub
Journal:  Clin Dev Immunol       Date:  2011-07-25

10.  Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.

Authors:  M Million; M Maraninchi; M Henry; F Armougom; H Richet; P Carrieri; R Valero; D Raccah; B Vialettes; D Raoult
Journal:  Int J Obes (Lond)       Date:  2011-08-09       Impact factor: 5.095

View more
  17 in total

Review 1.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.

Authors:  Junli Ma; Qihang Zhou; Houkai Li
Journal:  Nutrients       Date:  2017-10-16       Impact factor: 5.717

2.  Gut microbiota, fatty liver disease, and hepatocellular carcinoma.

Authors:  Huikuan Chu; Brandon Williams; Bernd Schnabl
Journal:  Liver Res       Date:  2018-02-21

Review 3.  Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.

Authors:  Sonia Villapol
Journal:  Cell Mol Neurobiol       Date:  2017-10-03       Impact factor: 5.046

Review 4.  The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.

Authors:  Ya-Hui Ding; Lin-Yan Qian; Jie Pang; Jing-Yang Lin; Qiang Xu; Li-Hong Wang; Dong-Sheng Huang; Hai Zou
Journal:  Oncotarget       Date:  2017-06-02

Review 5.  Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease.

Authors:  Jana Hundertmark; Oliver Krenkel; Frank Tacke
Journal:  Front Immunol       Date:  2018-10-18       Impact factor: 7.561

Review 6.  Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.

Authors:  Tatsuo Kanda; Taichiro Goto; Yosuke Hirotsu; Ryota Masuzaki; Mitsuhiko Moriyama; Masao Omata
Journal:  Int J Mol Sci       Date:  2020-02-23       Impact factor: 5.923

Review 7.  Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  Int J Mol Sci       Date:  2016-04-01       Impact factor: 5.923

8.  Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?

Authors:  Valerio Nobili; Lorenza Putignani; Antonella Mosca; Federica Del Chierico; Pamela Vernocchi; Anna Alisi; Laura Stronati; Salvatore Cucchiara; Marco Toscano; Lorenzo Drago
Journal:  Arch Med Sci       Date:  2016-09-06       Impact factor: 3.318

Review 9.  Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease.

Authors:  Jessica Lambertz; Sabine Weiskirchen; Silvano Landert; Ralf Weiskirchen
Journal:  Front Immunol       Date:  2017-09-19       Impact factor: 7.561

10.  A Bugs Battle on Behalf of the Liver.

Authors:  Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2016-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.